This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Unattended death
R18_UNATTE_DEATH
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
335 |
4. Check minimum number of eventsNone |
335 |
5. Include endpointsNone |
335 |
6. Filter based on genotype QC (FinnGen only) |
329 |
Control definitions (FinnGen only)
- Control exclude
- R18_ILL_D_UNKNO_CAUSES_MORTA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R9[5-9]
- Name in latin
- Mors sine assessione
Similar endpoints
↥List of similar endpoints to
Unattended death
based on the number of shared cases.
Similar with more cases:
- Ill-defined and unknown causes of mortality
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 329 | 92 | 237 |
| Unadjusted period prevalence (%) | 0.09 | 0.03 | 0.11 |
| Median age at first event (years) | 71.82 | 71.43 | 71.97 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 335
- Matched controls
- 3350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R98
ICD-10 Finland
Unattended death
+∞
307.7
335
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.7
31.2
54
93
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
5.6
28.6
61
128
N05AH03
ATC
olanzapine; systemic
4.9
15.8
37
83
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.6
15.7
26
42
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.0
15.6
*
399
N05AX08
ATC
risperidone; systemic
3.5
15.4
60
197
N05AA02
ATC
levomepromazine; systemic
5.6
15.2
30
58
WW200, ,
SPAT
0.1
12.8
6
460
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
13.9
12.6
21
16
A98
ICPC
Health maint/preventive medicine
0.4
12.4
206
2647
N07BB01
ATC
disulfiram; oral
4.6
12.2
30
70
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
11.8
10.2
18
16
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.9
9.9
22
47
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
8.4
9.5
20
25
N05AH04
ATC
quetiapine; oral
2.5
9.2
70
326
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
11.9
9.2
16
14
188
Kela drug reimbursment
Psychosis requiring demanding treatment
28.3
8.5
11
*
M01AH05
ATC
etoricoxib; oral
0.5
8.4
81
1367
N05AC02
ATC
thioridazine; oral
9.3
8.1
16
18
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
22.7
8.1
11
5
N03AG01
ATC
valproic acid; systemic, rectal
3.5
8.0
28
85
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.6
8.0
27
80
F10.25
ICD-10 Finland
Alcohol dependence continuous use
8.1
8.0
17
22
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
11.2
7.9
14
13
N05CD07
ATC
temazepam; oral
2.4
7.7
60
282
OAB43, ,
SPAT
0.1
7.6
*
265
F20.9
ICD-10 Finland
Schizophrenia, unspecified
7.9
7.5
16
21
EB1VA, ,
NOMESCO Finland
0.0
7.3
*
176
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.6
7.0
17
27
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
7.8
7.0
15
20
K92.0
ICD-10 Finland
Haematemesis
4.2
6.7
18
45
N06AA12
ATC
doxepin; systemic
3.3
6.6
25
80
N05AF03
ATC
chlorprothixene; systemic
6.4
6.5
16
26
R83
ICPC
Respiratory infection other
0.2
6.5
8
334
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.2
6.5
6
295
N05AB03
ATC
perphenazine; systemic, rectal
4.2
6.4
17
42
I51.7
ICD-10 Finland
Cardiomegaly
27.2
6.3
8
*
P15
ICPC
Chronic alcohol abuse
4.1
6.2
17
43
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
6.5
6.2
15
24
N06AB04
ATC
citalopram; systemic
2.0
6.2
73
404
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
161
2334
0.40
14.92
20.1
15.6
75.69
75.64
ml/min/173m2
0.01
126
1952
178
2444
0.42
13.43
4.0
5.1
2.42
2.59
mmol/l
1.54
152
2227
200
2621
0.41
13.42
23.1
19.6
85.43
85.73
umol/l
0.03
200
2621
199
2608
0.42
13.16
10.9
10.9
28.47
26.04
u/l
0.33
185
2512
61
1295
0.35
12.67
2.1
2.6
—
—
—
0
0
171
2365
0.43
12.55
3.6
4.6
1.35
1.39
mmol/l
0.73
143
2153
214
2708
0.42
12.32
28.1
24.4
131.30
135.31
g/l
2.63
203
2658
214
2708
0.42
12.32
27.8
24.2
4.38
4.48
e12/l
1.61
200
2626
214
2707
0.42
12.27
27.8
24.2
39.15
40.01
%
1.09
185
2534
214
2707
0.42
12.27
27.8
24.2
237.04
237.01
e9/l
0.00
201
2635
175
2386
0.44
12.01
3.6
4.6
4.26
4.43
mmol/l
1.21
148
2194
171
2304
0.47
10.18
3.4
4.1
1.34
1.29
mmol/l
0.36
143
2086
174
2322
0.48
9.88
7.0
6.2
43.85
41.00
mmol/mol
1.75
155
2149
208
2604
0.47
9.67
23.2
19.6
138.72
139.58
mmol/l
2.97
197
2538
209
2610
0.47
9.59
23.1
19.8
4.01
4.02
mmol/l
0.19
198
2545
186
2403
0.49
9.04
4.1
4.8
6.67
6.09
mmol/l
3.57
158
2171
200
2489
0.51
7.85
19.7
16.9
21.47
26.60
mg/l
1.88
169
2039
168
2181
0.54
7.10
4.0
4.3
2.22
1.99
mu/l
0.99
150
1939
39
797
0.42
6.23
2.5
3.1
0.91
0.80
ug/l
0.19
27
529
138
1829
0.58
5.44
3.5
4.1
16.61
13.55
mm/h
1.13
123
1663
94
1380
0.56
5.42
3.6
5.0
5.39
2.58
ug/l
0.51
84
1225
72
1114
0.55
4.83
3.6
4.4
22.10
21.52
%
0.12
34
545
133
1726
0.62
4.33
3.4
3.4
15.27
14.89
pmol/l
0.83
116
1519
159
1974
0.63
4.19
7.5
7.8
95.41
80.25
u/l
0.95
147
1840
27
530
0.47
3.67
3.7
3.9
296.86
272.01
ng/l
0.03
22
449
42
710
0.53
3.63
3.0
2.8
408.26
7456.23
umol/l
3.24
34
610
134
1696
0.65
3.58
4.7
4.8
507.73
4159.95
e6/l
0.86
11
37
124
1577
0.66
3.27
4.6
3.4
68.54
57.13
u/l
0.80
114
1460
37
629
0.54
3.22
2.3
2.6
—
—
—
0
0
14
337
0.39
3.17
1.1
1.3
3.45
7.54
u/ml
—
8
114
22
440
0.46
3.13
1.7
1.2
2.45
1.04
u/ml
0.73
13
121
68
968
0.63
2.97
2.3
2.2
69.55
76.11
nmol/l
0.79
58
841
13
47
2.84
2.85
1.9
2.7
5.84
5.01
e9/l
0.28
13
47
114
1446
0.68
2.81
9.5
9.0
4.63
4.26
e9/l
1.02
106
1272
83
1115
0.66
2.73
1.8
2.1
84.98
91.60
pmol/l
0.78
52
595
90
1185
0.67
2.66
2.5
2.7
—
—
—
0
0
17
350
0.46
2.62
1.0
1.2
54.14
33.58
iu/ml
—
7
117
18
81
2.29
2.59
1.6
1.4
—
—
—
0
0
13
50
2.66
2.56
2.1
3.3
68.23
59.94
%
1.00
13
50
6
11
5.53
2.55
11.2
12.5
758.17
783.64
nmol/l
—
6
11
6
11
5.53
2.55
17.3
15.5
1275.50
1465.09
nmol/l
—
6
11
0
66
0.00
2.43
0.0
2.1
—
—
—
0
0
42
264
1.68
2.35
2.8
3.9
2.33
1.91
mmol/l
0.46
33
214
16
294
0.52
1.80
1.4
1.4
—
—
—
0
0
79
1006
0.72
1.79
3.1
2.7
232.26
163.01
ug/l
0.80
70
914
68
875
0.72
1.63
2.3
3.4
2.35
2.34
mmol/l
0.17
60
761
66
845
0.73
1.52
2.7
2.1
772.13
281.20
u/l
0.46
61
787
0
45
0.00
1.51
0.0
1.2
—
—
—
0
0
16
87
1.88
1.48
1.9
2.3
15.00
88.52
ug/min
—
6
49
118
1383
0.77
1.44
6.5
6.4
13.13
12.09
umol/l
0.21
106
1310
37
257
1.49
1.41
2.6
2.0
1.85
1.62
%
0.66
32
220
102
1212
0.77
1.37
6.4
5.8
1.19
1.21
mmol/l
1.91
94
1090
119
1386
0.78
1.36
26.8
18.0
1.38
1.36
inr
0.08
45
399
35
487
0.69
1.31
2.0
1.9
—
—
—
0
0
0
33
0.00
1.17
0.0
1.0
—
—
—
0
0
105
1221
0.80
1.14
4.5
3.9
0.00
0.00
estimate
0.50
30
262
106
1230
0.80
1.13
4.6
3.9
0.00
0.00
estimate
-0.00
28
233
5
21
2.40
1.09
1.0
1.3
—
—
—
0
0
105
1215
0.80
1.08
6.1
5.4
0.00
0.00
estimate
-0.00
27
244
5
108
0.45
1.02
1.2
1.8
—
—
—
0
0
7
131
0.52
1.01
1.6
1.7
—
—
—
0
0
0
29
0.00
0.98
0.0
1.3
—
—
—
0
0
6
118
0.50
0.96
1.2
2.0
—
—
—
0
0
42
533
0.76
0.91
3.1
3.3
2.46
2.46
mmol/l
0.09
36
459
37
476
0.75
0.88
2.3
2.9
1.00
1.05
e6/l
0.05
25
295
6
111
0.53
0.84
1.0
1.9
31.67
39.56
u/l
—
6
98
146
1603
0.84
0.82
5.5
4.7
7.46
6.82
mmol/l
2.20
134
1518
26
347
0.73
0.80
2.1
1.9
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
26
345
0.73
0.77
2.1
1.8
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
8
136
0.58
0.74
11.3
4.3
24.60
25.17
mmol/l
—
8
127
17
240
0.69
0.73
2.8
3.0
278.06
236.68
ng/l
0.28
17
215
104
1165
0.84
0.72
4.7
5.0
33.20
34.80
g/l
1.85
91
1086
36
448
0.78
0.69
2.4
3.1
4.15
1.25
e6/l
0.48
24
269
7
116
0.60
0.69
1.6
1.6
—
—
—
0
0
6
105
0.56
0.62
5.5
1.8
10.38
10.53
g/l
—
6
90
73
832
0.84
0.61
3.2
3.8
7.15
11.52
mg/mmol
0.65
46
550
5
30
1.68
0.61
1.0
1.4
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
7
114
0.61
0.59
5.0
1.8
3.14
3.57
g/l
—
7
100
7
114
0.61
0.59
5.0
1.8
7.24
7.40
g/l
—
7
100
7
114
0.61
0.59
5.0
1.8
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
1.97
—
0
13
36
294
1.25
0.57
7.1
3.9
—
—
—
0
0
120
1305
0.87
0.54
6.8
6.6
1.20
1.21
mmol/l
0.52
92
1090
11
158
0.69
0.54
1.3
1.3
—
—
—
0
0
7
109
0.63
0.49
5.0
1.8
2.37
3.02
g/l
—
7
95
16
210
0.75
0.48
1.9
2.7
56.57
62.03
ml/min/173m2
—
7
97
86
948
0.88
0.47
4.0
3.3
2588.47
1874.37
ng/l
0.64
79
811
30
249
1.22
0.43
2.0
2.3
0.19
0.21
g/l
0.51
25
228
6
94
0.63
0.42
1.0
1.0
—
—
—
0
0
5
32
1.57
0.42
2.2
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
3.8
—
104.10
—
0
17
0
17
0.00
0.41
0.0
2.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
23
280
0.81
0.40
4.6
7.0
122.04
120.66
g/l
0.13
23
273
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
91
977
0.91
0.32
4.7
4.1
—
—
—
0
0
14
175
0.79
0.31
2.3
1.6
—
—
—
0
0
28
323
0.85
0.30
9.5
8.1
—
—
—
0
0
8
106
0.75
0.29
4.1
3.0
—
—
—
0
0
110
1164
0.92
0.28
5.7
4.2
39.11
49.74
ng/l
0.55
93
896
6
83
0.72
0.24
1.3
1.3
—
—
—
0
0
73
780
0.92
0.23
2.8
3.4
0.48
0.49
e6/l
0.01
65
601
15
178
0.84
0.22
1.1
1.4
—
—
—
0
0
5
40
1.25
0.22
2.2
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
13.40
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
1.00
—
0
7
94
988
0.93
0.20
3.1
3.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
49
1.23
0.20
1.5
4.5
17.18
625.64
u/ml
—
6
44
14
118
1.19
0.19
3.0
5.6
2.44
1.57
%
0.58
14
109
40
367
1.10
0.19
5.5
5.9
1.06
1.04
mmol/l
0.15
34
337
5
66
0.75
0.17
1.0
1.4
—
—
—
0
0
5
66
0.75
0.17
2.2
1.8
—
—
—
0
0
6
80
0.75
0.15
1.3
1.6
—
—
—
0
0
62
592
1.06
0.12
2.0
1.8
1369.82
1147.68
nmol/l
1.36
47
456
46
435
1.07
0.12
2.2
2.4
2.29
2.26
g/l
0.17
40
394
6
57
1.05
0.08
1.5
1.2
—
—
—
0
0
5
62
0.80
0.08
2.0
1.4
—
—
—
0
0
5
62
0.80
0.08
2.0
1.4
—
—
—
0
0
22
208
1.06
0.05
6.1
3.6
2.56
1.78
mmol/l
0.56
17
155
62
606
1.03
0.04
1.6
1.8
358.70
7828229.59
pmol/l
0.50
47
511
70
713
0.98
0.03
2.3
2.1
3.80
3.17
mg/l
1.45
61
614
22
229
0.96
0.03
6.1
3.4
5.21
5.12
kpa
0.21
22
222
71
702
1.01
0.01
3.9
4.0
0.00
0.01
estimate
0.50
23
231
82
812
1.01
0.01
3.6
3.4
31.46
32.98
u/l
0.26
76
771
35
343
1.02
0.01
4.5
6.4
1.32
1.32
mmol/l
0.00
29
267
20
194
1.03
0.00
1.3
1.6
—
—
—
0
0
83
836
0.99
0.00
2.8
2.5
53.66
63.43
u/l
0.89
74
780
13
132
0.98
0.00
1.5
2.2
5.96
4.48
ug/l
0.12
13
111
15
148
1.01
0.00
5.7
8.0
24.37
24.56
mmol/l
0.08
15
141
34
342
0.99
0.00
4.6
6.3
10.32
11.58
kpa
0.70
34
325
11
111
0.99
0.00
2.8
2.3
405.09
326.03
ug/l
0.20
11
105
34
341
1.00
0.00
4.6
6.4
5.22
5.08
kpa
0.26
34
322
20
203
0.98
0.00
4.8
6.5
25.00
24.34
mmol/l
0.36
20
193
19
195
0.97
0.00
1.8
3.9
58.00
89.03
ng/l
0.96
11
174
30
304
0.99
0.00
2.5
3.2
5.96
9.10
umol/l
1.38
23
265
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
101.43
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
-0.00
0.0
1.0
—
119.00
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
-0.00
1.3
3.0
152.50
60.31
u/ml
—
6
59
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
50
1.00
-0.00
2.2
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
1276.67
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
-0.00
2.0
1.8
—
—
—
0
0
7
74
0.94
-0.00
1.7
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
-0.00
0.0
4.0
—
128.44
—
0
9
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_UNATTE_DEATH – Unattended death
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).